Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.23% |
| 2 | Healthcare | 7.53% |
| 3 | Financials | 7.5% |
| 4 | Industrials | 5.83% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
226
PUT
Salesforce
CRM
$165B
| $152M | 0.08% |
1,149,300
+162,300
| +16% | +$23.7M |
|
227
CALL
Amgen
AMGN
$226B
| $152M | 0.08% |
578,700
-12,000
| -2% | -$3.22M |
|
228
PUT
Ulta Beauty
ULTA
$22.2B
| $151M | 0.08% |
322,500
+75,700
| +31% | +$32.6M |
|
229
PUT
CVS Health
CVS
$121B
| $150M | 0.08% |
1,612,800
+549,800
| +52% | +$53.1M |
|
230
International Flavors & Fragrances
IFF
$21.4B
| $150M | 0.08% |
1,428,932
+1,361,980
| +2,034% | +$134M |
|
231
CALL
Morgan Stanley
MS
$343B
| $150M | 0.08% |
1,759,900
+673,600
| +62% | +$57.4M |
|
232
Accenture
ACN
$109B
| $149M | 0.08% |
558,990
-336,905
| -38% | -$93.2M |
|
233
PUT
Caterpillar
CAT
$393B
| $149M | 0.08% |
622,400
+174,200
| +39% | +$37.9M |
|
|
SCHW
234
Charles Schwab
SCHW
$190B
| $149M | 0.08% |
1,788,061
-1,618,293
| -48% | -$126M |
|
235
PUT
Abbott
ABT
$193B
| $149M | 0.08% |
1,354,500
-104,500
| -7% | -$10.8M |
|
236
Ally Financial
ALLY
$13.6B
| $148M | 0.08% |
6,058,768
+4,105,417
| +210% | +$109M |
|
237
Elevance Health
ELV
$86.6B
| $148M | 0.08% |
288,389
+34,421
| +14% | +$17.5M |
|
238
TE Connectivity
TEL
$62B
| $148M | 0.08% |
1,287,943
+52,780
| +4% | +$6.27M |
|
|
HZNP
239
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $146M | 0.08% |
+1,284,500
| New | +$107M |
|
240
JPMorgan Chase
JPM
$965B
| $145M | 0.08% |
1,082,594
+25,723
| +2% | +$3.26M |
|
|
241
PUT
Elevance Health
ELV
$86.6B
| $145M | 0.08% |
282,900
+29,300
| +12% | +$14.9M |
|
242
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $143M | 0.08% |
3,784,700
-1,726,900
| -31% | -$63.7M |
|
243
CALL
Texas Instruments
TXN
$250B
| $142M | 0.08% |
862,300
+219,100
| +34% | +$36.5M |
|
244
Netflix
NFLX
$326B
| $142M | 0.08% |
4,819,920
-16,370
| -0.3% | -$459K |
|
245
Kimberly-Clark
KMB
$36.8B
| $141M | 0.08% |
1,041,678
+108,498
| +12% | +$13.8M |
|
246
United Therapeutics
UTHR
$21.9B
| $141M | 0.08% |
508,273
-73,437
| -13% | -$18.5M |
|
247
MongoDB
MDB
$38B
| $141M | 0.08% |
714,665
+113,609
| +19% | +$20.2M |
|
248
Zoetis
ZTS
$31.3B
| $140M | 0.08% |
957,411
+349,780
| +58% | +$51.8M |
|
249
Albemarle
ALB
$15.4B
| $140M | 0.08% |
646,719
+43,323
| +7% | +$11.5M |
|
250
Coca-Cola
KO
$376B
| $140M | 0.08% |
2,203,635
-2,177,182
| -50% | -$131M |
|
Similar funds
Millennium Management's Q4 2022 Portfolio in Review
As of Q4 2022, Millennium Management held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management's Q4 2022 filing shows 848 new, 2,517 increased, 2,492 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Millennium Management added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Millennium Management's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Millennium Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Millennium Management's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Millennium Management opened 848 new positions and closed 1,332 in Q4 2022.
- Millennium Management's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.